
Prevalence of Clinical Cardiovascular Disease Risk Factors Among HIV Infected Patients on Anti-Retroviral Treatment in a Tertiary Hospital in Ethiopia
Author(s) -
Esubalew Woldeyes,
Henok Fisseha,
Hailu Abera Mulatu,
Abiy Ephrem,
Henok Benti,
Mehari Wale Alem,
Ahmed Ibrahim Ahmed
Publication year - 2022
Publication title -
hiv/aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.752
H-Index - 22
ISSN - 1179-1373
DOI - 10.2147/hiv.s362459
Subject(s) - medicine , dyslipidemia , framingham risk score , nevirapine , body mass index , risk factor , population , logistic regression , regimen , obesity , disease , viral load , immunology , human immunodeficiency virus (hiv) , environmental health , antiretroviral therapy
Anti-retroviral treatment has improved mortality of human immunodeficiency virus (HIV) infected patients, which is offset by an increasing burden of cardiovascular diseases (CVD). Data regarding prevalence of cardiovascular disease risk factors in HIV infected patients in Ethiopia are very scarce. The aim of this study was to determine the prevalence of CVD risks and associated factors in patients with HIV.